New Hires - Market Access

Modulettes

PROPOSED URRICULUMS

Utilize this curriculum to ensure that your new hires possess a solid foundational knowledge of market access and policy issues. This curriculum can help establish a standardized and structured approach to market access training, particularly if your current training program faces an unmet need. By implementing this curriculum, you can effectively level-set your market access teams and improve their understanding of crucial market access concepts and policies.

  • Provides an in-depth review of the 340B program and its impact on reimbursement and community-based practices

  • Outlines how clinical pathways are developed and used in oncology care decision making

  • Outlines how clinical guidelines are developed and guide in oncology care decision making

  • Part 1 of our landscape series provides a big picture on cancer patients today and the novel therapies used to treat them

  • Details the Enhancing Oncology Model, a CMS value-based payment program

  • Defines the term “financial toxicity” and how it applies to patients with cancer

  • Follows an outpatient specialty drug used in cancer from drug manufacturer to patient

  • Follows a physician-administered drug used in cancer through the pharmaceutical supply chain

  • Explains the basics of a GPO and the contracting process

  • Provides key information on the benefits of electronic health records, especially in relation to quality reporting and the shift to value-based care

  • Provides a detailed view of the IRA and what it means to the delivery of cancer care, patients, and providers

  • Details MACRA and the Quality Payment Program as part of the shift towards performance-adjusted payments and away from fee-for-service payments

  • A deep dive into Medicare infrastructure, including an explanation of how Medicare reimbursement works across different settings

  • Also called Buy and Bill, this one details Medicare Part B services and physician reimbursement

  • Explores the dynamics of Medicare Part D prescription drug programs

  • Expalins CMS-approved compendia and off-label use

  • Part 2 of our landscape series gives a look inside an oncology practice and how it functions, including how patients are administered care and how costs are managed

  • Details the many policies payers and PBMs may use to contain costs in the pharmacy benefit

  • Part 3 in our landscape series explores the larger trends affecting oncology practices and how they treat cancer patient today

  • Explains the various incentive-based payment programs that are moving providers and healthcare teams from fee-for-service to value-based healthcare

  • Defines the various terms used in physician-administered drug reimbursement

  • Defines the terms and what they mean in the distribution process of drugs used in cancer care